HCV-IGM ANTIBODY

The HCV IgM Antibody Test is a laboratory blood test designed to detect Immunoglobulin M (IgM) antibodies against the Hepatitis C Virus (HCV). It may be used as part of the evaluation of hepatitis C infection in conjunction with clinical assessment and other laboratory investigations.

Hepatitis C is a viral infection that primarily affects the liver. It spreads through contact with infected blood, including unsafe injections, transfusion of unscreened blood products, sharing contaminated needles, and, less commonly, from mother to child during childbirth or through sexual contact. Many people with hepatitis C have no symptoms during the early stages, while others may develop fatigue, loss of appetite, nausea, abdominal discomfort, dark urine, jaundice (yellowing of the skin and eyes), and elevated liver enzymes.

When the body is exposed to the Hepatitis C virus, the immune system produces antibodies against the virus. Laboratory evaluation of hepatitis C typically includes HCV antibody testing followed by HCV RNA (PCR) testing to confirm active infection. Depending on the laboratory protocol and clinical indication, an HCV IgM Antibody Test may be requested as part of the serological assessment.

It is important to note that current international guidelines primarily recommend total anti-HCV antibody testing and HCV RNA molecular testing for the diagnosis of hepatitis C. Therefore, results of an HCV IgM antibody test should always be interpreted together with clinical findings, liver function tests, and confirmatory molecular testing when indicated.

Doctors may recommend this test for individuals with suspected viral hepatitis, unexplained liver inflammation, abnormal liver function tests, or those with risk factors for hepatitis C exposure.

Benefits of the Test

• Supports the evaluation of hepatitis C virus infection.
• Detects immune response to HCV.
• Assists in investigating unexplained liver disease.
• Useful alongside liver function tests and HCV RNA testing.
• Helps evaluate individuals with hepatitis symptoms.
• Requires only a simple blood sample.
• Supports early clinical assessment.
• Provides valuable information when interpreted with other HCV investigations.

Why Doctors Recommend This Test

Doctors may recommend the HCV IgM Antibody Test when hepatitis C infection is suspected or when evaluating unexplained liver disease. The results are interpreted together with HCV total antibody testing, HCV RNA (PCR), liver function tests (LFTs), and the patient's medical history to determine whether active infection is present.

Preparation Before the Test

No special preparation is required.

You may eat and drink normally unless instructed otherwise by your healthcare provider. Inform your doctor about your symptoms, medications, previous hepatitis infections, liver disease, or recent exposure to infected blood. A blood sample is collected from a vein for laboratory analysis.

Normal Reporting Time

Typically: 1–3 Working Days

Reporting time may vary depending on laboratory methodology.

Who Should Take This Test?

This test may be recommended for:

• Individuals with suspected hepatitis C infection.
• Patients with abnormal liver function tests.
• People with unexplained jaundice.
• Individuals exposed to infected blood.
• Healthcare workers after occupational exposure.
• People who inject drugs or share needles.
• Patients undergoing evaluation for viral hepatitis.
• Individuals with chronic liver disease.
• People referred by hepatologists or infectious disease specialists.
• Anyone advised by their healthcare provider.